Business
hVIVO and Imutex to present at IVW 2019
hVIVO and Imutex to present at IVW 2019.
About this update from Hvivo Plc
[{"type":"text","content":"\n \nRNS Number : 3748U hVIVO plc 29 March 2019 \n\nhVIVO plc\n(\"hVIVO\" or the \"Company\")\n \nhVIVO and Imutex Limited to present at the Influenza Vaccines for the World (IVW 2019) conference at the Royal College of Physicians of Edinburgh, Scotland\n \nLondon, UK 29 March 2019: hVIVO plc (AIM: HVO), an industry leading clinical development services business pioneering human disease models based upon viral and allergen challenge, confirms that the Company and its joint venture, Imutex Limited, will present at the Influenza Vaccines for the World (IVW 2019) conference on 2-4 April 2019 at the Royal College of Physicians of Edinburgh, Edinburgh, Scotland, UK.\n \nIVW 2019 is an international conference and exhibition in an important series of influenza vaccine meetings focused on 'Influenza Vaccination Issues'. The IVW series is an international forum for world renowned experts in the field of influenza vaccines and related issues (adjuvants / delivery / vaccination strategies) to report on the latest data and trends associated with current and new influenza vaccines / technologies and their availability / delivery / implementation worldwide.\n \nPresentation details are as follows:\n \nTitle: FLU-v, a broad spectrum influenza vaccine: cross-reactivity and field results\nPresenter: Dr Olga Pleguezuelos, Imutex (SEEK)\nDate and time: Tuesday, 2 April 2019, Session 3,12.10-12.40\nLocation: Royal College of Physicians of Edinburgh, Scotland, UK\n \nTitle: The future for FLU-v: Efficacy results from an H1N1 challenge study\nPresenter: Dr Emma James, Imutex (SEEK)\nDate and time: Tuesday, 2 April 2019, Session 4, 14.30-15.00\nLocation: Royal College of Physicians of Edinburgh, Scotland, UK\n \nTitle: The human viral challenge and the evaluation of novel/universal vaccines\nPresenter: Dr Rob Lambkin-Williams, hVIVO\nDate and time: Wednesday, 3 April 2019, Session 6, 09.30...